Shares of several COVID-19 vaccine developers sank fast enough to reflect investor jitters about vaccine policy given RFK’s ...
About $1.6 billion has been invested in research that has yielded little progress, disappointing many who suffer with the ...
Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...
The company records direct sales and alliance revenues from its partner, BioNTech BNTX, for the COVID-19 vaccine, Comirnaty, and product revenues from its oral antiviral pill for COVID ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
For people with long Covid, finding some relief today rests ... right to make well-informed decisions about accessing promising drugs with reasonable safety profiles. Without treatment, 400 ...
The ease with which women have been able to get abortion pills could also be up for reconsideration under Trump. During the ...
The Centers for Disease Control and Prevention (CDC) has issued new advice regarding vaccines for COVID and pneumonia. The ...